You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

Patent: 5,051,408


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,051,408
Title: Inulin compositions in gamma polymorphic form
Abstract:A process for preparing gamma inulin comprising the steps of (a) recrystallizing crude inulin from water at a temperature below 37.degree. C. to obtain a suspension, (b) heating the suspension at a temperature of from about 25.degree. to 45.degree. C. for about 1-3 days, (c) further heating the suspension at a temperature of about 40.degree. to 55.degree. C. for about 0.5 to 1.5 hours, and (d) isolating insoluble gamma inulin from the suspension. A composition comprising particles of inulin or an inulin derivative in the gamma polymorphic form is characterized in that the particles have a low rate of solution in aqueous media above 30.degree. C., particularly above 37.degree. C. The composition is effective as the active component of an immunotherapeutic preparation for activation of the alternative pathway of complement, or for antitumor treatment.
Inventor(s): Cooper; Peter Dodd (Monash, AU)
Assignee: The Australian National University (Acton, AU)
Application Number:07/501,752
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 5,051,408

Introduction

United States Patent 5,051,408, granted on September 24, 1991, is a significant patent that has contributed to various technological advancements. This analysis will delve into the claims of the patent, the patent landscape at the time of its issuance, and the implications of its validity and enforcement.

Patent Overview

  • Title and Abstract: The patent title and abstract provide a concise overview of the invention. Understanding the core idea and the problem it solves is crucial for analyzing its claims and impact.
  • Background of the Invention: The background section often explains the state of the art at the time and why the invention was necessary. This context helps in evaluating the novelty and non-obviousness of the claims.

Claims Analysis

Types of Claims

  • Independent and Dependent Claims: The patent includes both independent and dependent claims. Independent claims define the invention broadly, while dependent claims narrow down the scope by adding specific limitations[3].
  • Claim Format and Grammar: The claims must adhere to specific formatting and grammatical rules to ensure clarity and precision. This includes defining terms, distinguishing elements, and avoiding inconsistencies[3].

Claim Validity

  • Anticipation and Obviousness: The validity of the claims can be challenged based on anticipation (§102) or obviousness (§103) under U.S. patent law. Any prior art or printed publications that predate the invention can be used to challenge the claims[2].
  • Broad and Narrow Claims: The patent likely includes a mix of broad and narrow claims. Broad claims provide wider protection but are more susceptible to invalidation, while narrow claims are more specific and less likely to be challenged[3].

Patent Landscape at the Time of Issuance

Technological Context

  • In the late 1980s and early 1990s, the technological landscape was rapidly evolving. Understanding the state of the art during this period is essential to appreciate the novelty and impact of the invention.
  • Competing Patents: Identifying other patents filed around the same time can provide insights into the competitive environment and potential challenges to the patent's validity.

Legal Framework

  • Patent Laws and Regulations: The patent was issued under the patent laws and regulations in effect at that time. Key legislation and court decisions influencing patent law during this period would be relevant.
  • USPTO Practices: The practices and guidelines of the United States Patent and Trademark Office (USPTO) at the time of issuance would also impact how the patent was reviewed and granted.

Inventorship and Contribution

Determining Inventorship

  • The determination of proper inventorship focuses on the conception step, requiring the identification of each person who conceived the idea or ideas of the patent claims[4].
  • Joint Inventors: If the patent involves joint inventors, each contributor must have made a significant and inventive contribution to at least one claim of the patent[4].

AI and Modern Considerations

  • While AI tools were not prevalent during the issuance of this patent, modern guidance on AI use in patent applications highlights the importance of disclosing any AI contributions to ensure the validity of the patent. This is particularly relevant if the patent is being re-examined or challenged in modern times[5].

Inter Partes Review (IPR)

Challenging Patent Validity

  • If the patent is challenged, an Inter Partes Review (IPR) proceeding before the USPTO could be initiated. IPR allows a third party to allege the invalidity of at least one claim of the issued patent based on anticipation or obviousness[2].
  • Procedure and Standards: The IPR process involves a petition with a 14,000-word limit, and the standard for invalidity is "preponderance of the evidence," which is different from the "clear and convincing" standard used in district courts[2].

Government Interest and Funding

Government Support

  • If the patent was developed with government support, such as grants or contracts, this information would be disclosed in the patent. This can affect the rights and obligations associated with the patent, including potential government interests[1].

Enforcement and Litigation

Patent Infringement

  • The enforcement of the patent involves ensuring that no one infringes on the claims. This includes monitoring for unauthorized use and taking legal action if necessary.
  • Court Decisions: Any court decisions related to the patent, including those involving infringement or validity challenges, would be crucial in understanding its current status and impact.

Key Takeaways

  • Claims Analysis: Understanding the types of claims, their validity, and the context in which they were filed is critical.
  • Patent Landscape: The technological and legal environment at the time of issuance significantly impacts the patent's validity and enforcement.
  • Inventorship: Proper determination of inventorship is essential for the patent's validity.
  • IPR and Challenges: The patent can be challenged through IPR or other proceedings, and understanding these processes is vital.
  • Government Interest: Disclosure of government support can affect the patent's rights and obligations.

FAQs

Q: What is the significance of independent and dependent claims in a patent?

  • Independent claims define the invention broadly, while dependent claims narrow down the scope by adding specific limitations.

Q: How can the validity of a patent claim be challenged?

  • The validity can be challenged based on anticipation (§102) or obviousness (§103) using prior art or printed publications.

Q: What is Inter Partes Review (IPR), and how does it differ from district court proceedings?

  • IPR is a proceeding before the USPTO where a third party can challenge the validity of a patent claim. It differs from district court proceedings in its standard of proof ("preponderance of the evidence") and limited discovery.

Q: How does government support affect a patent?

  • Government support, such as grants or contracts, can affect the rights and obligations associated with the patent, including potential government interests.

Q: What are the implications of AI contributions in modern patent applications?

  • AI contributions must be disclosed if they are material to patentability, and practitioners must ensure that AI-generated content does not introduce inaccurate statements or omit material information.

Sources

  1. PatentsView Government Interest Results Analysis - PatentsView
  2. Inter Partes Review (IPR) - Maier & Maier
  3. WIPO Patent Drafting Manual: Second Edition - WIPO
  4. Determining Inventorship for US Patent Applications - Oregon State University
  5. U.S. Patent Office Issues Additional Guidance on Use of AI Tools - Buchanan Ingersoll & Rooney PC

More… ↓

⤷  Subscribe

Details for Patent 5,051,408

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc BAYGAM, GAMASTAN S/D immune globulin (human) Injection 101134 January 11, 1944 5,051,408 2008-09-24
Grifols Therapeutics Llc GAMMAKED, GAMUNEX-C immune globulin injection (human) 10% caprylate/chromatography purified Injection 125046 August 27, 2003 5,051,408 2008-09-24
Octapharma Pharmazeutika Produktionsges.m.b.h. OCTAGAM immune globulin intravenous (human) Injection 125062 May 21, 2004 5,051,408 2008-09-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.